Furthermore, PrognoScan-based Kaplan-Meier survival analysis revealed a correlation between higher Amigo2 expression levels and shorter survival times in 177 colon cancer patients (p < 0.05, Fig. 6c). The gene discussed is AMIGO2; the disease is malignant colon neoplasm.